No.3-1, Park Street
3rd Floor Nangang District
Taipei 11503
Taiwan
886 2 2652 5999
https://www.tty.com.tw
Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees:
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Yung-Min Chiang | Chief Financial Officer & Chief Auditor | N/A | N/A | N/A |
Ms. Shu-Wen Wang | Accounting Officer | N/A | N/A | N/A |
Ms. Shu-Fen Huang | Chief Legal & Compliance Officer | N/A | N/A | N/A |
Wei-Ying Yin | Director of Public Affairs Department | N/A | N/A | N/A |
Mr. Jen-Yang Chang | Chief Human Resource Officer | N/A | N/A | N/A |
Ms. Si-Yuan Yang | Senior Vice President | N/A | N/A | N/A |
Mr. Allen Chu | Head of Intensive Care Business Unit | N/A | N/A | N/A |
Ms. Ching-Lan Hou | General Manager | N/A | N/A | N/A |
TTY Biopharm Company Limited, together with its subsidiaries, engages in the development and sale of pharmaceutical and chemical drugs in Taiwan and internationally. The company operates through Oncology Business Unit, Health Care Unit, Anti-infection Business Unit, Domestic Cardiovascular and Gastrointestinal Drugs Business Unit, China Medicine Business Unit, and Other segments. It offers oncology drugs under the Lipo-Dox, Lonsurf, UFUR, TS-1, Pexeda, Gemmis, Oxalip, Irino, Epicin, Tynen, Anazo, Folina, Thado, Andason, Ivic, Asadin, Leavdo, Painkyl, Megest, Episil, Otril, Zobonic, Yondelis, and Pemazyre names for anti-cancer and supplementary treatments. The company also provides anti-infection drugs under the Brosym, Colimycin, Cubicin, Lipo-AB, Agrippal, Cepiro, Flusine, Maxtam, Metacin, and Flucelvax names for anti-infection and flu. In addition, it offers healthcare related drugs under the Algitab, Alginos, Alginos Fresh, Bio-Cal Plus, and Sulfin names for digest system, osteoporosis, and metabolism. Further, the company engages in the selling functional foods; and import and export trading and investment activities. TTY Biopharm Company Limited was incorporated in 1960 and is headquartered in Taipei, Taiwan.
TTY Biopharm Company Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.